Literature DB >> 507297

Sepsis in the management of complicated biliary disorders.

J M Holman, L F Rikkers, F G Moody.   

Abstract

Postoperative sepsis developed in 72 per cent of 25 patients with noncalculous proximal biliary tract obstruction. Six episodes of shock and one death resulted. Twenty-eight per cent of septic events occurred despite the administration of prophylactic antibiotics. The incidence of septic complications was similar regardless of the biliary drainage procedure used. Despite the advent of broad spectrum antibiotics and improved surgical techniques for biliary decompression, sepsis remains a serious and frequent complication in patients with chronic bile duct obstruction.

Entities:  

Mesh:

Year:  1979        PMID: 507297     DOI: 10.1016/0002-9610(79)90301-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  13 in total

1.  Impaired nonspecific cellular immunity in experimental cholestasis.

Authors:  P T Roughneen; D B Drath; A D Kulkarni; B J Rowlands
Journal:  Ann Surg       Date:  1987-11       Impact factor: 12.969

2.  Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice.

Authors:  F K Welsh; C W Ramsden; K MacLennan; M B Sheridan; G R Barclay; P J Guillou; J V Reynolds
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

3.  T-lymphocyte transformation in experimental obstructive jaundice: the role of serum-suppressive factors.

Authors:  R L Thompson; S Ranjbar; B J Rowlands
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

4.  Bacterial translocation and intestinal morphological findings in jaundiced rats.

Authors:  Pierpaolo Sileri; Sergio Morini; Giuseppe S Sica; Stefano Schena; Cristiana Rastellini; Achille L Gaspari; Enrico Benedetti; Luca Cicalese
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

5.  External biliary drainage plus bile acid feeding is not equal to internal drainage in preserving the cellular immunity following prolonged obstructive jaundice.

Authors:  K T Mok; B W Wang; H C Chang; S L Lin
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

6.  Soluble interleukin-2 receptor and soluble CD8 in liver cirrhosis and obstructive jaundice.

Authors:  F Wagner; C Assemi; C Lersch; R Hart; M Classen
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

7.  Bacterial translocation and gut microflora in obstructive jaundice.

Authors:  R W Parks; W D Clements; C Pope; M I Halliday; B J Rowlands; T Diamond
Journal:  J Anat       Date:  1996-12       Impact factor: 2.610

8.  Biliary decompression promotes Kupffer cell recovery in obstructive jaundice.

Authors:  W D Clements; M McCaigue; P Erwin; I Halliday; B J Rowlands
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

9.  Bacteriological study of transhepatically aspirated bile. Relation to cholangiographic findings in 295 patients.

Authors:  Y Suzuki; A Kobayashi; M Ohto; Y Tsuchiya; H Saisho; K Kimura; T Ono; K Okuda
Journal:  Dig Dis Sci       Date:  1984-02       Impact factor: 3.199

10.  Intracellular accumulation of unconjugated bilirubin inhibits phytohemagglutin-induced proliferation and interleukin-2 production of human lymphocytes.

Authors:  Y Haga; M A Tempero; D Kay; R K Zetterman
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.